51. Dresler CM, León ME, Straif K, Baan R, Secretan B. Reversal of risk upon quitting smoking. The Lancet
2006; 368: 348-349.........................................................................................................................................................101
54. Federman DG., Bravata DM., Kirsner RS. Peripheral Arterial Disease: A systemic disease extending beyond
the affected extremity. Geriatrics, 2004; 59: 26-36.....................................................................................................101
61. Frosst P, Blom HJ, Milos R, Goyette P, Shepparo CA, Mathews RG et al. A candidate genetic risk factor for
vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 1995; 10:111-
113...................................................................................................................................................................................101
67. Godoi LC. Avaliação da hemostasia em indivíduos assintomáticos portadores de mutações de importância
em trombofilia. 2002 150f. Dissertação (Mestrado em Ciências Farmacêuticas) Faculdade de Farmácia, UFMG,
Belo Horizonte................................................................................................................................................................102
70. Henker PK, Schmaier A, Wakefield TW. Vascular thrombosis due to hypercoagulable states IN Rutherford,
RB. Vascular Surgery, Philadelphia, Pennsylvania, 2005: 568-578..........................................................................102
76. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJC, Jakobs C, Bouter LM, Heine RJ,
Stehouwer CDA. Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease,
Especially in Non–Insulin- Dependent Diabetes Mellitus A Population-Based Study. Arterioscl Thromb Vasc
Biol,1998;18:133-138......................................................................................................................................................102
86. Kannel WB. The demographics of claudication and the aging American population. Vasc Med 1996;1:60-64.
.........................................................................................................................................................................................103
93. Kullo IJ, Bailey KR, Kardia SL et al. Ethnic differences in peripheral arterial disease in the NHLBI Genetic
Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med 2003; 8: 237-242..........................................104
100. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW et al. Paradoxical
vasoconstriction induced by acethylcholine in atherosclerotic coronary arteries. N Eng J Med. 1986; 315: 1046-
1051.................................................................................................................................................................................104
119. Pasterkamp G, Schoneveld AH , van Wolferen W, Hillen B, Clarijs RJG, Haudenschild CC, Borst C. The
Impact of Atherosclerotic Arterial Remodeling on Percentage of Luminal Stenosis Varies Widely Within the
Arterial System A Postmortem Study .Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:3057-3063.
.........................................................................................................................................................................................106
120. Pasterkamp G, Galis ZS, de Kleijn DPV. Expansive Arterial Remodeling: Location, Location, Location
Arterioscler. Thromb. Vasc. Biol. 2004; 24: 650 - 657...............................................................................................106
121. Pasternak RC, Criqui MH, Benjamin EJ, Fowkes GR, Isselbacher EM, McCullough PA et al.
Atherosclerotic Vascular Disease Conference: Writing GroupI: Epidemiology. Circulation 2004; 109: 2605-
2612.................................................................................................................................................................................106
123. Pinto X, Fiol C, Simeon JM et al. Risk factors of arteriopathy of the lower extremities: lipid and not lipid
factors. Med Clin (Barc). 1997;109:41-4......................................................................................................................106
137. Samson RH. Hypertension and patients with vascular disorders IN Rutherford, RB. Vascular Surgery,
Philadelphia, Pennsylvania, 2005: 618-629..................................................................................................................107
149. Smith SC, Milani RV, Arnett DL et al. Atherosclerotic vascular disease conference: writing group II: Risk
factors. Circulation 2004; 109:2613-2616....................................................................................................................108
155. Strandness Jr, DE. Hemodynamics and the Vascular Laboratory IN Coffman JD, Eberhardt RT.
Peripheral Arterial Disease Diagnosis and treatment. New Jersey, Humana Press 2003;55-73............................108